API
< Back to situations

This situation has concluded

It was preserved as a record on September 9; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.

[SITUATION] · [QUIET] · [HEALTH]

7 clusters · 40 sources · 19 days · First seen · Last updated

Sildenafil shows anti‑metastatic promise

Overview

Late July 2026 pre‑clinical work from U.S. and Israeli labs showed that sildenafil, the active ingredient of Viagra, blocks PDE5, raises cGMP, and sequesters cholesterol in lysosomes, suppressing metastatic spread in mouse models of breast, lung, colon and prostate cancer. The July 22 report detailed the same cholesterol‑dependent mechanism and noted that co‑administration with statins further reduced tumor‑cell migration. Analyses of Israeli health‑service records covering nearly five million patients found improved survival among cancer patients prescribed sildenafil, especially when combined with statins. A July 30 study in *Cancer Research* by Ayelet Erez and Yarden Ariav described the PDE5‑cGMP‑NPC1 pathway and confirmed the retrospective survival benefit. Follow‑up papers on July 31 and August 1 reiterated the mechanistic findings and emphasized that the National Cancer Institute views the repurposing approach as promising but experimental, warning against self‑medication. On August 3, a further pre‑clinical report from the Weizmann Institute and the U.S. National Cancer Institute reaffirmed these results, showing marked reductions in metastasis formation, especially when combined with statins. On August 6, a new *Cancer Research* article by the same collaborative team expanded the preclinical evidence, highlighting the strongest anti‑metastatic signals in breast, melanoma and lung cancers and announcing plans for clinical trials, particularly in triple‑negative breast cancer. The same day, researchers at the Weizmann Institute reported that sildenafil blocked cholesterol transport into tumor cells, reducing movement of human breast, lung and colon cancer cells, with the greatest effect in triple‑negative breast cancer. In mouse models, tumor spread to the lungs fell by more than 50%. A two-decade analysis of about five million Clalit health-system records showed a 26% lower five-year mortality risk for cancer patients using sildenafil, an effect amplified when patients also used statins. These findings reinforce the move toward clinical trials in women with triple‑negative breast cancer.

Entities

Weizmann Institute of Science · Ayelet Erez · Sildenafil (Viagra) · Statins · Sildenafil

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [HEALTH] 3 sources
    Sildenafil may help limit cancer metastasis, researchers find

    Scientists have found that sildenafil, the active ingredient in Viagra, may limit cancer metastasis by disrupting cholesterol trafficking within cancer cells, according to research from the Weizmann Institute.

  2. [HEALTH] 8 sources
    Viagra's active ingredient sildenafil shown to curb cancer metastasis

    Weizmann Institute researchers found sildenafil blocks cholesterol transport in tumor cells, reducing metastasis in labs and mouse models; patient data show a 26% lower five‑year mortality, with added benefit –

  3. [HEALTH] 2 sources
    Sildenafil shown to curb cancer metastasis in preclinical studies

    A Weizmann Institute and U.S. NCI study found sildenafil reduces cancer cell migration and metastasis in lab models, with enhanced effect when paired with statins; health‑record data suggest improved survival,

  4. [HEALTH] 9 sources
    Viagra's active ingredient sildenafil shown to limit cancer metastasis in preclinical study

    A Weizmann Institute study in Cancer Research found sildenafil, Viagra’s active ingredient, blocks cholesterol use in cancer cells, reducing metastasis in lab models, especially with statins; clinical trials –

  5. [HEALTH] 7 sources
    Weizmann Institute study finds Viagra may block cancer metastasis

    Weizmann Institute researchers report that Viagra (sildenafil) blocks tumor cholesterol transport, reducing metastasis in lab studies and linking to higher survival in patients, especially with statins.

  6. [HEALTH] 4 sources
    Viagra's active ingredient shows potential to block cancer metastasis

    Weizmann Institute researchers report sildenafil (Viagra) blocks a cholesterol‑related pathway, reducing cancer cell spread in labs and improving survival in Israeli patient data, but clinical trials are needed

  7. [HEALTH] 7 sources
    Viagra (sildenafil) may block cancer metastasis in preclinical research

    US‑Israel researchers found sildenafil may hinder cancer metastasis in mouse models by disrupting cholesterol transport, especially when paired with statins.

Sources

brasilemfolhas.com · deia.eus · deultimominuto.net · dol.com.br · elsol.com.ar · ensegundos.do · fehmarn24.de · hrvatska-danas.com · instinctmagazine.com · jwire.com.au · katalogfirm.pl · knowridge.com · kopalniawiedzy.pl · kurierverlag.de · latestly.com · leinetal24.de · m.nautil.us · mag.newsweek.com · mayacomunicacion.com.mx · mobil.krone.at · multimediosprisma.com · n1info.hr · nationalgeographic.com.es · oglobo.globo.com · okdiario.com · orienteeringonline.net · priskalkulator.no · santiago30caballeros.com · sdpnoticias.com · secolo-trentino.com · sibiu100.ro · sintinta.com.ar · tessenderlo.com · thej.ca · theneutral.pk · timesnownews.com · tocka.com.mk · tribunaonline.com.br · xeu.com.mx · xeu.mx

This summary has been updated 13 times: see revision history